Three-month treatment with pioglitazone reduces circulating levels of S100A8/A9 (MRP8/14) complex, a biomarker of inflammation, without changes in body mass index, in type 2 diabetics with abdominal obesity

✍ Scribed by Hideaki Nakatsuji; Ken Kishida; Tohru Funahashi; Iichiro Shimomura

• Book ID: 116407368
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 256 KB
• Volume: 95
• Category: Article
• ISSN: 0168-8227
• DOI: 10.1016/j.diabres.2011.11.018